IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Matrix Capital Management Company, LP

Q3 2025 Holdings

Filed 2025-11-13 | 3 holdings | $106.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Maze Therapeutics Inc(MAZE)COM578784100$42.9M1,653,68440.2%
Aura Biosciences Inc(AURA)COM05153U107$42.8M6,922,87040.1%
Zentalis Pharmaceuticals Inc(ZNTL)COM98943L107$21.1M13,959,97319.7%